Trials that use: Odds ratio
New to this method? Read the tutorial →
5,976 results
- Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of AIN457 in Adults (18-65 Years) With Psoriatic Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055): Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Tolerability of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety and Tolerability of Seroguard Use: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Seroguard Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03640559).
- Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety and Tolerability Study of N6022 in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study of N6022 in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01147406).
- Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men.: Complete Statistical AnalysisIndependent statistical analysis of Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy: Complete Statistical AnalysisIndependent statistical analysis of Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety and Tolerability Study of SHP626 in Overweight and Obese Adults: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study of SHP626 in Overweight and Obese Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety Evaluation of Aline HA, an Implanted Cross-Linked HA Device: Complete Statistical AnalysisIndependent statistical analysis of Safety Evaluation of Aline HA, an Implanted Cross-Linked HA Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01708213).
- Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy: Complete Statistical AnalysisIndependent statistical analysis of Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety of 4CMenB Exposure During Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Safety of 4CMenB Exposure During Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02640677).
- Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals’ Boostrix™ Vaccine in Healthy Vietnamese Children: Complete Statistical AnalysisIndependent statistical analysis of Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6: Complete Statistical AnalysisIndependent statistical analysis of Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04084171).
- Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With AR: Complete Statistical AnalysisIndependent statistical analysis of Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to
- Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase: Complete Statistical AnalysisIndependent statistical analysis of Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement: Complete Statistical AnalysisIndependent statistical analysis of Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.: Complete Statistical AnalysisIndependent statistical analysis of Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.: primary endpoint results, effect estimate with confidence interval, sample-size…
- Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety of Intravenous Apramycin in Adults: Complete Statistical AnalysisIndependent statistical analysis of Safety of Intravenous Apramycin in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05590728).
- Safety of Intravenous Neridronic Acid in CRPS: Complete Statistical AnalysisIndependent statistical analysis of Safety of Intravenous Neridronic Acid in CRPS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02972359).
- Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South Korea: Complete Statistical AnalysisIndependent statistical analysis of Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South Korea: primary endpoint results,…
- Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren’s Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety of Vitamin D Supplementation in Older Persons: Complete Statistical AnalysisIndependent statistical analysis of Safety of Vitamin D Supplementation in Older Persons: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00681590).
- Safety Study for an All-in-One Body and Personal Lubricant: Complete Statistical AnalysisIndependent statistical analysis of Safety Study for an All-in-One Body and Personal Lubricant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01189617).
- Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif: Complete Statistical AnalysisIndependent statistical analysis of Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01469156).
- Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study of Albuterol Spiromax® in Subjects With Asthma: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Albuterol Spiromax® in Subjects With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01698320).
- Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety Study of Cosmetic Tissue Augmentation in People of Color: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Cosmetic Tissue Augmentation in People of Color: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01147172).
- Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age: primary endpoint results, effect…
- Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777): Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety Study of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008): Complete Statistical AnalysisIndependent statistical analysis of Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01678807).
- Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02039401).